Johnson & Johnson vs Veeva Systems Inc. — Stock Comparison
Q·Score Breakdown
7.1
Bullish
Overall
8.9
Very Bullish
Quality
Health
Growth
Valuation
Sentiment
JNJ
High-quality business with 26% return on equity and 22% profit margins.
⚠ earnings contracting 53% year-over-year.
VEEV
Clean balance sheet with low leverage (0.0× debt-to-equity).
Analyst Consensus
BUY
Target $252.42 (+11.1%)
24 analysts
BUY
Target $264.46 (+54.1%)
28 analysts
Fundamentals
JNJ
VEEV
26.3×
Trailing P/E
31.5×
17.9×
Forward P/E
17.4×
21.8%
Profit Margin
28.4%
68.0%
Gross Margin
75.5%
26.4%
ROE
13.9%
9.9%
Revenue Growth
16.0%
-52.9%
Earnings Growth
23.2%
0.33
Beta
1.10
—
Price / Book
—
$546.9B
Market Cap
$28.2B
$146 – $252
52-Week Range
$148 – $311
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →